Daniel Schwartz
Physician M.D. / Surgeon • Nephrology
United States
Personal Collections
Contributions
- Dec 24th, 2022
- Dec 24th, 2022
-
Dec 24th, 2022
Commented on Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
-
Dec 24th, 2022
Commented on Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
-
Dec 24th, 2022
Commented on Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
-
Dec 24th, 2022
Commented on Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial.
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Dec 24th, 2022
- Fetch more »